PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jresmedsciHomeCurrent issueInstructionsSubmit article
 
J Res Med Sci. Feb 2012; 17(2): 186–189.
PMCID: PMC3525040
Mood disorders insight scale: Validation of Persian version
Hajar Ahmadi Vazmalaei,1 Atefeh Ghanbari Jolfaei,2 and Amir Shabani3
1Psychiatrist, Tehran University of Medical Sciences, Tehran, Iran.
2Assistant Professor, Department of Psychiatry, Mental Health Research Center, Tehran University of Medical Sciences, Tehran, Iran.
3Associate Professor, Department of Psychiatry, Mental Health Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Address for correspondence: Atefeh Ghanbari Jolfaei, Assistant Professor, Department of Psychiatry, Mental Health Research Center, Tehran University of Medical Sciences, Tehran, Iran. E-mail: draghj/at/yahoo.com
Received April 5, 2011; Revised June 6, 2011; Accepted January 12, 2012.
Background:
Lack of insight in patients with bipolar I disorder has been associated with poor course and clinical outcome and compromised therapeutic compliance. Therefore, it is important to evaluate insight and use more specialized scales such as Mood Disorder Insight Scale (MDIS) in these patients. Our objective in this study was to assess validity and reliability of Persian version of MDIS.
Materials and Methods:
A hundred forty five bipolar patients were selected from Iran Hospital of Psychiatry. They were interviewed by The Persian Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorder, 4th edition's (DSM-IV) axis I disorders (SCID-I) and the Scale to Assess Unawareness of Mental Disorder (SUMD). The translated version of MDIS in Persian was subsequently completed by patients.
Results:
The internal consistency was satisfactory (Cronbach alpha coefficients = 0.8). The test-retest reliability (coefficient alpha) was 0.95 (p < 0.01). Construct validity and concurrent validity were supported by factor analysis and Spearman rank correlation between MDIS and SUMD (0.85). Conclusions: Persian version of the MDIS could be a useful instrument for assessing insight in patients with bipolar I disorder.
Keywords: Validation Studies, Mood Disorder Insight Scale, Bipolar Disorder, Iran
Insight to a mental disorder has been defined as an awareness of a variety of disorder-related issues such as symptoms, probable cause and source of these symptoms, need of treatment and repercussions of the disorder.[13] Insight is not an all-or-none phenomenon; a patient may have insight into some signs and symptoms of the disorder not to others.[3]
Most of the studies regarding insight have given much attention to psychotic disorders especially schizophrenia,[113] but some literature has focused on insight in mood disorders particularly bipolar-I-disorder (BID) and according to them in bipolar patients poor insight was associated with poor compliance to medical and psychological treatment and poor course and outcome.[1421]
A variety of insight scales have been developed but most of them are suitable for psychotic patients and cannot reflect the insight of patients with mood disorders; therefore, it is better to use more specialized scales such as Mood Disorder Insight Scale (MDIS) for assessing insight in these patients. Sturman and Sproule determined test-retest reliability (r = 0.75, n = 45) and also validity of MDIS using clinician ratings (r = 0.49, n = 69).[22] The objective of this study was to assess validity and reliability of Persian version of MDIS.
Preparing the Persian version of MDIS
The original English text of the MDIS[22] was translated into Persian by four bilingual (English/Persian) translators who were all psychiatrist and assistant professor of university.
They reached an agreement on finalized translation of items. Then it was back translated into English by another professional bilingual (English/Persian) translator who had not seen the original items of MDIS. The back-translated version was compared with the original MDIS by primary translators and appropriate modifications were made in the translated text. The process of translation back-translation was repeated until reaching an acceptable equivalence between original MDIS and back-translated version.
Patients
Subjects were selected from Persian speaking outpatients and inpatients with diagnosis of BID disorders. The sampling was nonrandomized referred. to Iran Hospital of Psychiatry, Tehran, Iran, from December 2008 to September 2009. The diagnoses were made based on the Persian Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorder, 4th edition's (DSM-IV) axis I Patient aged 18-65 years and gave informed consent and had cognitive, educational and mental ability for reading and responding the items were included. The exclusion criteria were having a severe disorder either in terms of behavior or language that made the interview and responding to the items almost impossible (e.g., moderate to severe mental retardation, severe dementia and severe agitation). All subjects were volunteers and did not receive compensation for their participation. Finally, 145 (61% males) patients were recruited. The method was ethically approved by research committee of mental health research center.
Instruments
The Persian Structured Clinical Interview for DSM-IV axis I disorders (SCID-I)
SCID, a gold standard and widely used clinical tool for diagnosis of psychiatric disorders based on DSM-IV criteria, was used as a diagnostic tool in this study. It has been shown to have reliability and feasibility and have fair to good diagnostic agreements for most diagnostic categories (kappa = 0.55). Its acceptable specificity and sensitivity has been shown on a large sample of Iranian patients.[23]
The Scale to Assess Unawareness of Mental Disorder (SUMD)
This instrument is a semi-structured interview with 9 items, and assesses: 1) Awareness of having a mental disorder or psychiatric symptoms, 2) Awareness of need to and effects of medication, and 3) Awareness of social consequences of mental disorder.[3] Each item includes current and past state and each state is scored on a Likert scale ranging from 1 to 3: 0 (not applicable), 1 (aware), 2 (somewhat aware/unaware), and 3 (severely unaware). The higher score indicates lower insight. In the present study, the SUMD was the gold standard comparator against the MDIS and the inter-rater reliability of the SUMD was determined on 45 patients. Amador et al. indicated that the median inter-rater intra-class correlation coefficients (ICC) for the SUMD was 0.89.[3] In another study, it was reported that there was 100% agreement (ICC = 1.00) between SUMD ratings on several dimensions and the diagnoses which were made according to DSMIV-TR criteria by a psychiatrist.[24]
The Mood Disorder Insight Scale (MDIS)
MDIS is composed of eight items. It is a self-report instrument assessing three basic sections of illness-awareness consisting of 1) awareness of mental disorder, 2) Attribution of symptoms and 3) awareness of need for treatment through both current and past episodes of mood disorder.[22]
Subjects can respond to each item as to whether they agree, disagree, or are unsure. The MDIS takes between 2 and 3 minutes to be administered. Maximum score for each of the sub-scores is 4 and maximum score for the whole scale is 12. The higher scores mean higher insight. In Sturman and Sproule study, the test-retest reliability of the scale was 0.75 (p < 0.01) and there were significant correlations between the scores on psychiatrists ratings and the MDIS total score (r = 0.49, p < 0.001) and subscores.[22]
Procedure
After collecting some demographic and clinical data, SCID and SUMD were performed by two trained resident of psychiatry for all patients. Then, the patients filled out the MDIS. Test-retest reliability was evaluated through a second test three days later, face to face for inpatients and by phone for outpatients.
To analyze data, we used SPSS version 11.5 (Chicago, IL, USA). Descriptive methods, intra-class correlation, factor analysis and Spearman correlation was used.
Demographic and clinical data and their relationship with MDIS and SUMD scores were shown in table 1. The test-retest reliability (coefficient alpha) of the MDIS was 0.95 (p < 0.01) Inter-rater reliability of SUMD was 0.95 (p < 0.01). Internal consistency analysis of Persian MDIS showed Cronbach alpha coefficients as 0.83 and intra-class correlation coefficients as 0.82.
Table 1
Table 1
Relationship between demographic characteristics and MDIS and SUMD scores
Table 2 shows correlation coefficients between items of MDIS. Spearman rank correlation between MDIS and SUMD was 0.85 and this result supported the concurrent validity of MDIS. The mean scores of SUMD in patients were 18.25 ± 6.82 (MAX = 27, MIN = 6). The mean scores of MDIS in patients were 6.07 ± 3.43 (MAX = 10, MIN = 1).
Table 2
Table 2
Correlation between items of MDIS
Factor analyses revealed that Eigen value of the first and second question was over 1, accounting for 67.6% of the variance in MDIS scores. Scoring of the first item was opposite of other items and because of that, MDIS had 2 factors, “poor insight” and “good insight”. The result confirmed the construct validity (Table 3).
Table 3
Table 3
Factor Analysis of MDIS items
Test-retest reliability and the internal consistency showed the reliability of Persian version of the MDIS. There are limitations associated with the use of SUMD as the gold standard for validating MDIS. SUMD was designed for psychotic patients and some of its items asked the patients awareness about psychotic symptoms. Although bipolar patients may experience psychosis, these items are not suitable for those bipolar patients who did not experience psychotic symptoms. In Sturman and Sproule study, the psychiatrists rated the patients insight on 10-cm visual analogue scales and MDIS scores were compared with these psychiatrist ratings of insight.[22] Considering that MDIS also have two items about psychotic experiences, we thought that using a standard scale would be better and visual analogue scales does not seem to be reliable. Accordingly, we used SUMD.
In our study, the mean scores of MDIS in BID patients were lower than participants of Sturman and Sproule study. In opposition to that study, most of our participants were inpatients and as it was seen in both studies, insight in outpatients was significantly higher than inpatients.[22] Like other studies, there were no significant differences in MDIS and SUMD scores based on different demographic characteristics.[10,12,24]
The limitation of the present study was that we did not evaluate severity of symptoms, duration of treatment and type of episodes and these characteristics were related to insight scores in some studies but not in others.[11,14,15,1719,22,2527] We recommend that MDIS could be used for assessing insight in other mood disorders. Furthermore, it has advantages in predicting the clinical course and the compliance in Iranian patients suffering BID.
Acknowledgments
The authors would like to express their sincere appreciations to Dr Sayed Vahid Shariat, Dr Vandad Sharifi and Dr Aliakbar Nejatisafa for helping in translating MDIS.
Footnotes
Source of Support: Nil
Conflict of Interest: None declared
1. Greenfeld D, Strauss JS, Bowers MB, Mandelkern M. Insight and interpretation of illness in recovery from psychosis. Schizophr Bull. 1989;15(2):245–52. [PubMed]
2. David AS. Insight and psychosis. Br J Psychiatry. 1990;156:798–808. [PubMed]
3. Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM. Assessment of insight in psychosis. Am J Psychiatry. 1993;150(6):873–9. [PubMed]
4. Lin IF, Spiga R, Fortsch W. Insight and adherence to medication in chronic schizophrenics. J Clin Psychiatry. 1979;40(10):430–2. [PubMed]
5. Schwartz RC. Insight and illness in chronic schizophrenia. Compr Psychiatry. 1998;39(5):249–54. [PubMed]
6. Debowska G, Grzywa A, Kucharska-Pietura K. Insight in paranoid schizophrenia--its relationship to psychopathology and premorbid adjustment. Compr Psychiatry. 1998;39(5):255–60. [PubMed]
7. Smith TE, Hull JW, Goodman M, Hedayat-Harris A, Willson DF, Israel LM, et al. The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder. J Nerv Ment Dis. 1999;187(2):102–8. [PubMed]
8. Young DA, Zakzanis KK, Bailey C, Davila R, Griese J, Sartory G, et al. Further parameters of insight and neuropsychological deficit in schizophrenia and other chronic mental disease. J Nerv Ment Dis. 1998;186(1):44–50. [PubMed]
9. David A, van OJ, Jones P, Harvey I, Foerster A, Fahy T. Insight and psychotic illness. Cross-sectional and longitudinal associations. Br J Psychiatry. 1995;167(5):621–8. [PubMed]
10. Kemp R, David A. Psychological predictors of insight and compliance in psychotic patients. Br J Psychiatry. 1996;169(4):444–50. [PubMed]
11. David A, Buchanan A, Reed A, Almeida O. The assessment of insight in psychosis. Br J Psychiatry. 1992;161:599–602. [PubMed]
12. Smith TE, Hull JW, Santos L. The relationship between symptoms and insight in schizophrenia: a longitudinal perspective. Schizophr Res. 1998;33(1-2):63–7. [PubMed]
13. Carroll A, Fattah S, Clyde Z, Coffey I, Owens DG, Johnstone EC. Correlates of insight and insight change in schizophrenia. Schizophr Res. 1999;35(3):247–53. [PubMed]
14. Ghaemi SN, Pope HG., Jr Lack of insight in psychotic and affective disorders: a review of empirical studies. Harv Rev Psychiatry. 1994;2(1):22–33. [PubMed]
15. Ghaemi SN, Stoll AL, Pope HG., Jr Lack of insight in bipolar disorder. The acute manic episode. J Nerv Ment Dis. 1995;183(7):464–7. [PubMed]
16. Michalakeas A, Skoutas C, Charalambous A, Peristeris A, Marinos V, Keramari E, et al. Insight in schizophrenia and mood disorders and its relation to psychopathology. Acta Psychiatr Scand. 1994;90(1):46–9. [PubMed]
17. Ghaemi SN. Insight and psychiatric disorders: a review of the literature, with a focus on its clinical relevance for bipolar disorder. Psychiatr Ann. 1997;27(12):782–90.
18. Ghaemi SN, Boiman E, Goodwin FK. Insight and outcome in bipolar, unipolar, and anxiety disorders. Compr Psychiatry. 2000;41(3):167–71. [PubMed]
19. Amador XF, Flaum M, Andreasen NC, Strauss DH, Yale SA, Clark SC, et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry. 1994;51(10):826–36. [PubMed]
20. Swanson CL, Jr, Freudenreich O, McEvoy JP, Nelson L, Kamaraju L, Wilson WH. Insight in schizophrenia and mania. J Nerv Ment Dis. 1995;183(12):752–5. [PubMed]
21. Peralta V, Cuesta MJ. Lack of insight in mood disorders. J Affect Disord. 1998;49(1):55–8. [PubMed]
22. Sturman ED, Sproule BA. Toward the development of a Mood Disorders Insight Scale: modification of Birchwood's Psychosis Insight Scale. J Affect Disord. 2003;77(1):21–30. [PubMed]
23. Sharifi V, Assadi SM, Mohammadi MR, Amini H, Kaviani H, Semnani Y, et al. A Persian translation of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition: psychometric properties. Compr Psychiatry. 2009;50(1):86–91. [PubMed]
24. Kao YC, Liu YP. The Beck Cognitive Insight Scale (BCIS): translation and validation of the Taiwanese version. BMC Psychiatry. 2010;10:27. [PMC free article] [PubMed]
25. Dell’Osso L, Pini S, Tundo A, Sarno N, Musetti L, Cassano GB. Clinical characteristics of mania, mixed mania, and bipolar depression with psychotic features. Compr Psychiatry. 2000;41(4):242–7. [PubMed]
26. McEvoy JP, Apperson LJ, Appelbaum PS, Ortlip P, Brecosky J, Hammill K, et al. Insight in schizophrenia. Its relationship to acute psychopathology. J Nerv Ment Dis. 1989;177(1):43–7. [PubMed]
27. Markova IS, Berrios GE. The assessment of insight in clinical psychiatry: a new scale. Acta Psychiatr Scand. 1992;86(2):159–64. [PubMed]
Articles from Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences are provided here courtesy of
Medknow Publications